/
PSCR
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
10% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $881.4K | $789.0K |
| Cost of revenue | $0 | $0 | $0 | $187.1K | $224.5K |
| Gross profit | $0 | $0 | $0 | $694.3K | $564.5K |
| Gross margin | — | — | — | 78.8% | 71.5% |
| R&D | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$32.8K | −$32.4K | −$38.3K | −$146.7K | −$298.1K |
| EBITDA | −$32.4K | −$38.3K | −$45.2K | −$70.8K | −$293.0K |
| Net income | −$32.8K | −$32.4K | −$38.3K | −$145.2K | −$7.2M |
| Net margin | — | — | — | -16.5% | -910.4% |
| EPS (diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.08 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.07
Price
$0.00
Implied upside
+36203%
Peer comparison
PROTO SCRIPT PHARMA
PROTO SCRIPT PHARMA
Held by traders on TradeandTell
No one on the platform currently holds PSCR.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PSCR as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PSCR yet.